In conclusion, it was possible to perceive that juçara fruit supplementation modulated the serum fatty acids profile and could contribute for the reduction of the metabolic disease risk through the epigenetic modulation in obese individual monocytes—since the MUFAs predicted the DNA methylation promoter protein by MeCP2. The gene discussed is MECP2; the disease is metabolic disease.